Weight of the bleeding impact on early and late mortality after percutaneous coronary intervention

Gjin Ndrepepa1, Elena Guerra, Stefanie Schulz

  • 1Deutsches Herzzentrum, Lazarettstrasse 36, 80636, Munich, Germany, ndrepepa@dhm.mhn.de.

Insights

Bleeding after percutaneous coronary intervention (PCI) significantly increases early and late mortality risk. While bleeding is the primary driver of 30-day deaths, late mortality is influenced by other cardiovascular risk factors.

Area of Science:

  • Cardiology
  • Clinical Research
  • Patient Outcomes

Background:

  • The link between bleeding and mortality following percutaneous coronary intervention (PCI) requires further investigation.
  • Understanding this association is crucial for optimizing patient care and reducing adverse events post-PCI.

Purpose of the Study:

  • To examine the impact of bleeding on both early (30-day) and late (30-day to 1-year) mortality in patients undergoing PCI.
  • To identify bleeding as a predictor of mortality in the context of PCI procedures.

Main Methods:

  • A large cohort study of 14,180 patients undergoing PCI.
  • Bleeding events were classified using Bleeding Academic Research Consortium (BARC) criteria within 30 days post-PCI.
  • Landmark analysis at 1 month was employed to differentiate early and late mortality risks associated with bleeding.

Main Results:

  • Patients experiencing bleeding within 30 days had a significantly higher risk of early mortality (adjusted hazard ratio [HR] = 5.00).
  • Bleeding also increased the risk of late mortality (30-day to 1-year; adjusted HR = 1.65), though to a lesser extent than early mortality.
  • Bleeding was the strongest predictor of 30-day mortality, while age and other cardiovascular risk factors were more dominant in late mortality.

Conclusions:

  • Bleeding following PCI is a significant independent risk factor for both early and late mortality.
  • The strong association of bleeding with early mortality underscores the need for vigilant monitoring and management of bleeding events.
  • While bleeding contributes to late mortality, its impact is partially mediated by the co-occurrence of other cardiovascular risk factors.

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
748
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.9K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
630